AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
Healthcare
AstraZeneca (LON: AZN) Receives US Approval for Lung Cancer Treatment
December 22, 2020 07:30 PM AEDT| By Kunal SawhneySummary AstraZeneca plc’s (LON: AZN) Tagrisso (osimertinib) has received approval in the US for the adjuvant medication of adult patients. The approval was received under the US Food and Drug Administration’s (FDA) Real-Time Oncolog.....
Moderna Very Close to Getting US FDA Emergency Approval for Its Vaccine
December 18, 2020 10:24 PM AEDT| By Hina ChowdharySummary On 17 December, a panel of independent US experts recommended the emergency approval for Moderna’s mRNA-based vaccine. Last week, the same panel had backed the Pfizer Inc/BioNTech SE vaccine. The Moderna vaccine has efficiency an.....
AstraZeneca (LON: AZN) UK Vaccine Trial Withdraw Sub-Group
December 15, 2020 08:07 PM AEDT| By Hina ChowdharySummary The clinical trial registers in the US showed that the British pharma major AstraZeneca PLC has removed children from the final stage trial of its Covid-19 vaccine in Britain. The Phase 3 trial of the vaccine consisted of more than 12,0.....
Why GSK (LON: GSK) and Sanofi's (EPA: SAN) Covid-19 vaccine got delayed to 2021-end?
December 12, 2020 07:11 PM AEDT| By Kunal SawhneySummary The Covid-19 vaccine jointly developed by Britain’s GSK and France’s Sanofi has been delayed to the end of 2021 Both the pharmaceutical companies are expected to start Phase 2b studies in February 2021 While the compani.....
AstraZeneca (LON: AZN) Vaccine Model Yet to Clear the Doubts of US Regulator
December 10, 2020 10:01 PM AEDT| By Kunal SawhneySummary The executive vice-president at AstraZeneca biopharmaceuticals R&D Sir Menelas Pangalos has expressed his doubts over early FDA approval for their vaccine AstraZeneca has been facing criticism since it paused its Phase 3 trials in S.....
Allergy Therapeutics (LON: AGY) Shareholders Refuse to Pass Crucial Resolution At AGM
December 09, 2020 08:10 PM AEDT| By Team Kalkine MediaThe fully integrated specialty pharmaceutical group, Allergy Therapeutics PLC has said that all the resolutions which were proposed at its Annual General Meeting (AGM) on Tuesday were passed, barring one the resolution 10. Resolution 10 talks abou.....
Pfizer-BioNTech Covid-19 vaccine ensures ‘overwhelmingly high efficacy’: US FDA
December 09, 2020 07:45 PM AEDT| By Team Kalkine MediaSummary US FDA has commended the expeditious response of Pfizer and BioNTech in Covid-19 vaccine development Pfizer-BioNTech co-developed coronavirus vaccine exhibits safety and overwhelmingly high efficacy In a further advancement in the .....
What are the progressive developments made by N4 Pharma in collaboration with Nanomerics Limited?
December 08, 2020 01:41 AM AEDT| By Kunal SawhneySummary N4 Pharma Plc has reported an increase of 5.9% in operating loss during H1 FY20. The Company has started the first phase of research to test the stability of different formulations of Nuvec® in collaboration with Nanomerics Limited......
Pfizer-BioNTech Covid-19 vaccine just few hours away from the UK, says Deputy CMO
December 04, 2020 05:03 PM AEDT| By Kunal SawhneyThe United Kingdom administration is all set to get the very first doses of the clinically-approved coronavirus vaccine developed by Pfizer-BioNTech much ahead than other countries, especially the United States, where the vaccine is still under Foo.....
Is Covid-19 Vaccine Approval Hasty? FDA Commissioner Defends the Delay
December 03, 2020 08:18 PM AEDT| By Hina ChowdharySummary In a first, the UK has swiftly approved the Pfizer-BioNTech developed coronavirus vaccine The drug regulators across various nations including the US and the EU’s basket of countries are working on expediting the approval process .....
MHRA approves Pfizer-BioNTech vaccine for the UK, will be available from next week
December 02, 2020 07:21 PM AEDT| By Kunal SawhneyIn a historic development, the Medicines and Healthcare Products Regulatory Authority (MHRA) of the United Kingdom has given approval to the Pfizer-BioNTech vaccine. With this, the UK has become the first western country ahead of the US and Europe to...
AstraZeneca PLC (LON: AZN) to Sell the rights of Crestor, related medicines in Europe
December 02, 2020 03:20 AM AEDT| By Kunal SawhneyAstraZeneca PLC (LON: AZN) will be selling its rights of Crestor and some related medicines to Germany-based Grünenthal GmbH in more than 30 countries of Europe except the UK and Spain. The deal is worth up to $350 million. AstraZeneca will con...
Why Indivior (LON: INDV) shares suffered a 20%-crash on Friday
November 28, 2020 09:50 PM AEDT| By Hina ChowdharyShares of Indivior, the Chesterfield-headquartered pharmaceuticals company, crashed nearly 20 per cent at the close of the trading window on Friday, 28 November after the Slough-based healthcare-to-consumer goods manufacturer Reckitt Benckiser Group...
Pharma Stocks in Focus: Novartis (NYSE: NVS), Intercept Pharmaceuticals (NASDAQ: ICPT), Teva Pharmaceutical (NYSE: TEVA)
November 24, 2020 08:04 PM AEDT| By Kunal SawhneyThe pharmaceuticals industry has also been gripped by the aftereffects of coronavirus pandemic as even the pharma shares representing some of the major corporations like Novartis AG (NYSE: NVS), Intercept Pharmaceuticals Inc (NASDAQ: ICPT) have been...
COVID-19: AstraZeneca-Oxford’s Vaccine Shows 70 Per Cent Efficiency in Late-Stage Trials
November 24, 2020 01:41 AM AEDT| By Hina ChowdharySummary AstraZeneca said the Covid-19 vaccination, which the firm has been developing along with Oxford University, has shown a 70 per cent efficacy AstraZeneca CEO Pascal Soriot said the results are positive and show that it is highly effectiv.....
Pfizer Covid-19 Vaccine Is World's First To Seek Emergency US Approval
November 21, 2020 11:44 PM AEDT| By Kunal SawhneyPfizer and its partner BioNTech have submitted their report seeking early approvals from FDA for its Covid-19 vaccine The company has also started with its submissions in other countries such as Australia, Canada, Europe, Japan and the UK...
Pfizer-BioNTech vaccine to face stiff competition despite high success rate in trials
November 13, 2020 03:37 AM AEDT| By Kunal SawhneySummary The vaccine candidate was found to be 90 per cent efficient in preventing Covid-19 infection, making it one of the most effective against the virus. The vaccine, however, is not going to be available for at least a few months before the.....
Pfizer and BioNTech Skyrocket on Covid-19 Vaccine Results
November 10, 2020 08:23 PM AEDT| By Hina ChowdharyStock markets across the world witnessed a sharp uptick on Monday after initial data of a clinical trial showed that Pfizer and BioNTech’s vaccine candidate was more than 90 per cent effective in preventing COVID-19. Shares of both the pharm.....
Arix Bioscience plc’s VelosBio to be acquired by Merck
November 07, 2020 12:36 AM AEDT| By Team Kalkine MediaSummary NYSE listed Merck acquired VelosBio, a portfolio company of Arix Bioscience for US$2.75 billion Arix’s investment in VelosBio grew by 12 times Merck acquired VelosBio to bolster its oncology pipeline The global venture capit.....
TFF Pharmaceuticals releases results for Q3 2020
November 06, 2020 10:15 PM AEDT| By Kunal SawhneySummary TFF Pharmaceuticals Inc. was incorporated in 2018 as a clinical-stage biopharmaceutical company The company’s patented technology platform, Thin Film Freezing, or TFF helps it in developing and commercializing innovative drug prod.....
AI on the Rise: A Look at Top AI Companies and Their Stocks